SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001829126-22-014634
Filing Date
2022-07-26
Accepted
2022-07-26 08:33:58
Documents
13
Period of Report
2022-07-21
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K organicellregenrative_8k.htm   iXBRL 8-K 48041
2 EXHIBIT 99.1 organicellregenrative_ex99-1.htm EX-99.1 15732
  Complete submission text file 0001829126-22-014634.txt   238763

Data Files

Seq Description Document Type Size
3 XBRL LABEL FILE bpsr-20220721_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE bpsr-20220721_pre.xml EX-101.PRE 22363
5 XBRL SCHEMA FILE bpsr-20220721.xsd EX-101.SCH 2965
7 EXTRACTED XBRL INSTANCE DOCUMENT organicellregenrative_8k_htm.xml XML 3307
Mailing Address 4045 SHERIDAN AVENUE SUITE 239 MIAMI FL 33140
Business Address 4045 SHERIDAN AVENUE SUITE 239 MIAMI FL 33140 888-963-7881
Organicell Regenerative Medicine, Inc. (Filer) CIK: 0001557376 (see all company filings)

IRS No.: 474180540 | State of Incorp.: NV | Fiscal Year End: 1031
Type: 8-K | Act: 34 | File No.: 000-55008 | Film No.: 221104971
SIC: 3790 Miscellaneous Transportation Equipment